Tissue Regenix reports record revenues and positive EBITDA for 2023
LONDON: Tissue Regenix Group (AIM: TRX), a pioneer in regenerative medical devices, has reported its audited final results for the year ending December 31, 2023....
David Cocke appointed CFO at Tissue Regenix
LEEDS: Tissue Regenix, the regenerative medical devices company, has appointed David Cocke as Chief Financial Officer (CFO) and Director to the Board with immediate effect....